Outsourcing Pharma

AUGUST 11, 2020

American Gene Technologies has received the agencyâs approval to launch the first human trial for its lead HIV program, starting in Baltimore and DC.

FDA 145

FDA 145

pharmaphorum

AUGUST 10, 2020

Why did I do that? A common question I often ask myself after opening the biscuit packet for the third time in an hour. Only ten minutes before I had a mental argument with myself, which I thought I had won, promising not to eat another one until tomorrow. The process that goes on inside our heads, affecting the good and bad choices we make regarding our health every day, is the focus of health psychology and the growing interest around behavioural change.

Pharmaceutical Companies 125

Pharmaceutical Companies Pharmaceutical Companies 125

Fuld

AUGUST 10, 2020

Intelligence professionals respond to shifts in priorities, increased pressure from management, and fewer resources. The COVID-19 induced shutdowns have reset the agenda for strategy, intelligence, and insights professionals. Fuld + Company deployed this survey to better understand how corporate functions are adapting to these uncertain times and where they are delivering value to decision-makers.

78

78

Druggist

AUGUST 14, 2020

Gaviscon range of products is probably the most known brand of antacids in the UK. There are, however, several alternative products and drugs which can be used to help with symptoms of heartburn and indigestion. Today I will review 16 best Gaviscon alternative products and medicines. I will briefly discuss what Gaviscon is to get a better understanding of alternative treatments.

Packaging 75

Packaging Compounding 75

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

Outsourcing Pharma

AUGUST 10, 2020

Experts from the CRO offers insight on preparing for the changes to the pediatric oncology research requirements, which take effect next week.

105

105

pharmaphorum

AUGUST 12, 2020

A new digital therapy is aiming to tackle depression during the COVID-19 pandemic, using a brain stimulation headset and therapy app that claims to have similar beneficial effects to drugs but with fewer side-effects. Flow is the first drug-free at-home treatment of its type to be approved in the EU and UK. While using the Flow headset, patients engaged with a therapy app program, which offers personalised behavioural therapy in areas proven to reduce symptoms of depression, including nutrition,

118

118

Pharma Mirror

AUGUST 14, 2020

Animal feed represents the most profitable product type segment, presenting multiple investment opportunities for animal healthcare market operators. Top selling potential of animal feed additives is attributed to a growing focus on disease outbreak prevention rather than on curing disease afflicted animals. Animal healthcare market in China and Japan is especially observing robust demand growth.

52

52

Outsourcing Pharma

AUGUST 13, 2020

The cloud-based study technology firm has secured Series B funding to help develop and promote products like its clinical trial platform, StudyTeam.

72

72

pharmaphorum

AUGUST 14, 2020

After ditching its home-grown attempt at a coronavirus contact-tracing app for smartphones, the UK is ready to start pilot trials of a second version based on a platform developed by Apple and Google. The new NHS Test and Trace app is intended to be used as an add-on to the controversial national and local contact-tracing service, and was due to start initial trials yesterday on the Isle of Wight and among a group of NHS volunteers.

116

116

Pharma Times

AUGUST 13, 2020

If approved drug would offer a more flexible option for patients

FDA 63

FDA 63

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Pharma Mirror

AUGUST 14, 2020

QBiotics Group Limited (QGL), a life sciences company developing novel anticancer and wound healing pharmaceuticals, is pleased to announce that it has entered into an agreement with MSD (tradename of Merck & Co., Inc., Kenilworth, NJ, USA), to evaluate use of its lead molecule tigilanol tiglate, in combination with Keytruda(R) (pembrolizumab) in patients with unresectable.

52

52

Outsourcing Pharma

AUGUST 13, 2020

The US federal agency continues to keep busy offering resources, issuing EUAs and taking action related to the COVID-19 pandemic.

FDA 64

FDA 64

pharmaphorum

AUGUST 14, 2020

Verona Pharma is to develop its lung drug ensifentrine for patients with COVID-19, joining the legions of drug companies repurposing their medicines to fight the pandemic. Based in the UK and US, Verona is due to start a phase 3 trial of ensifentrine in chronic obstructive pulmonary disease (COPD) later this year after encouraging results in phase 2.

Compounding 112

Compounding FDA 112

Pharma Times

AUGUST 10, 2020

Pfizer becomes one of multiple external manufacturing organisations supporting scale-up of treatment

59

59

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Pharma Mirror

AUGUST 14, 2020

The positive impacts of pharmacists in supporting medication without harm are described in a new publication from the International Pharmaceutical Federation (FIP) released today. The World Health Organization reports that one in four patients is harmed by the care they receive in primary and ambulatory care settings, including harm from medicines. It estimates the global.

52

52

Outsourcing Pharma

AUGUST 10, 2020

The company is joining with ICER to help promote use of robust, repeatable indirect comparisons in health tech assessments.

57

57

pharmaphorum

AUGUST 11, 2020

In our latest UK Leaders article Pinder Sahota, UK general manager at Novo Nordisk, tells us how he hopes to bring the NHS and pharma together to improve outcomes in diabetes and other long-term conditions. Though Novo Nordisk is perhaps not as much of a household name as other pharma companies in the UK, it has a huge presence in diabetes, with a bigger market cap than the likes of GSK and AstraZeneca – and UK GM Pinder Sahota is keen to shout about the organisation that he describes as a “slee

Packaging 112

Packaging Communication 112

Pharma Times

AUGUST 12, 2020

NHS Confederation forecasts a surge in demand

56

56

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Pharma Mirror

AUGUST 13, 2020

Tadalafil is a prescription drug well-known to men over the age of 40 who usually have to deal with episodic or permanent erectile dysfunction. Yet there’s more to this substance than its typical use in managing impotence by improving the blood flow to the genitals. The substance is used in many other treatments and has. The post What Exactly Is Tadalafil?

52

52

Outsourcing Pharma

AUGUST 10, 2020

A leader from the clinical research solutions provider discusses the ways pandemic has shaken the trial industry, and how to tackle the obstacles.

52

52

pharmaphorum

AUGUST 10, 2020

Biogen’s Alzheimer’s drug aducanumab could be on the market in the next few months after the FDA accepted a clinical trial dossier and granted a fast Priority Review. The FDA reserves these quick reviews for drugs that have the potential to improve care standards for serious diseases. There have been no new drugs approved for Alzheimer’s since 2003 and those that are on the market are only able to treat the symptoms.

FDA 106

FDA 106

Pharma Times

AUGUST 10, 2020

Phase III study of drug in Crohn's disease is ongoing

55

55

Pharma Mirror

AUGUST 12, 2020

One of the most interesting types of cardiovascular pharmaceuticals around is antiarrhythmic drugs, which can change the way your heartbeats. Antiarrhythmic drugs help counteract abnormal heart rhythms resulting from the irregular electrical activity. These could include atrial fibrillation, atrial flutter, supraventricular tachycardia, and Wolff-Parkinson-White syndrome, among others.

52

52

Outsourcing Pharma

AUGUST 12, 2020

A partnership between two trial tech providers aims to create a more powerful, efficient and effective study solution for sites, sponsors and CROs.

52

52

pharmaphorum

AUGUST 10, 2020

Gilead has filed its COVID-19 drug remdesivir with the FDA, to treat patients with severe disease, under the brand name Veklury. The drug is currently available to US patients under an Emergency Use Authorisation for treatment of hospitalised patients with severe COVID-19. This filing is the last part of a rolling submission with the FDA that the company began in early April and could lead to a full licence for the drug, which was the first to show significant improvements in recovery time in pa

FDA 99

FDA Labelling 99

Pharma Times

AUGUST 13, 2020

UK biopharma company signs licensing agreement for emactuzumab

52

52

Pharma Mirror

AUGUST 12, 2020

Medical face shield can become as ubiquitous as masks, as new findings on the airborne spread of Covid-19 influence behavior and guidelines. According to a latest study by Future Market Insights, medical face shields market will grow at over 11% CAGR through 2030. Medical face shields prove to be an effective means for first line protection against.

52

52

Outsourcing Pharma

AUGUST 11, 2020

When growing market demand moved the Michigan CDMO to expand, it opted for a novel design-construction approach to building bigger digs.

52

52

pharmaphorum

AUGUST 12, 2020

A fellowship programme is looking for digital pioneers to design and lead service transformation projects in England’s NHS as the COVID-19 pandemic continues. DigitalHealth.London opens applications to its Digital Pioneer Fellowship programme, supporting change makers employed by NHS organisations in London to design and lead transformation projects underpinned by digital innovation.

98

98

Pharma Times

AUGUST 13, 2020

Public trial will launch today in Isle of Wight and other locations

52

52

Pharma Mirror

AUGUST 11, 2020

CPhI South East Asia – organised by Informa Markets – has been rescheduled to May 18-20, 2021 to give the ASEAN pharma community more time to recover and to mitigate any global disruptions caused by COVID-19. The decision to reschedule the event to 2021 reflects changing attendee needs. By moving to spring next year, we. The post CPhI South East Asia rescheduled for 2021 appeared first on Pharma Mirror Magazine.

52

52

Outsourcing Pharma

AUGUST 11, 2020

The medical organization has selected Rx.Health's TrialEngage, a set of digital tools geared toward supporting and improving decentralized trials.

52

52

pharmaphorum

AUGUST 11, 2020

Russia has become the first country in the world to approve a coronavirus vaccine, amid scepticism from international experts who have been unable to review or verify clinical data from the jab called ‘Sputnik V’ According to press reports the vaccine has been tested on one of President Vladimir Putin’s daughters. But World Health Organization leaders have said that they want to review the vaccine, called Sputnik V after Russia’s pioneering space probe, as the vaccine took just

Vaccines 98

Vaccines Immunization 98